Digitisation | April 19, 2022
AI driven Israeli company Embryonics ties-up with Jaslok Hospital
The data driven fertility company helps increase the success rate of fertility treatments
The data driven fertility company helps increase the success rate of fertility treatments
By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
Jamnagar’s contributions towards wellness will get a global identity with WHO’s Global Centre for Traditional Medicine
The Centre aims to channel the potential of traditional medicine by integrating it with technological advancements and evidence-based research
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round
It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research
Lilly may be eligible for up to US $ 225m in payments based upon the achievement of pre-specified development, regulatory and commercial milestones
Subscribe To Our Newsletter & Stay Updated
